NCT WISH Heats Up the Stage at the Korea-Japan Festival… Makes a Comeback with “I SPY”
Hanyang University and Kyung Hee University Festivals Kick Off One After Another… Surprise Reveal of New Song’s Choreography
Participating in Japan’s “a-nation” for the Third Consecutive Year
[Edaily Reporter Lee Youn-jung ] Ahead of their comeback, the group NCT WISH performed at festivals in both South Korea and Japan.
NCT WISH made consecutive appearances at Hanyang University’s ERICA Campus and Kyung Hee University’s International Campus on the 29th of last month, followed by a performance at Dongguk University’s festival on the 30th. On stage, they performed their hit songs, including “Hands Up,” “Make You Shine,” “poppop,” “Ode to Love,” and “Sticky,” and, ahead of their comeback, gave a surprise preview of part of the choreography for their title track “I SPY.” The group NCT WISH (Photo: SM Entertainment).
After touring university campuses across Korea, they moved their stage to Japan. On the 3rd, NCT WISH appeared at the Japanese music festival “a-nation 2026,” held at a special venue in Odaiba, Tokyo, for the third consecutive year, meeting local fans with their bright and upbeat stage presence and performances.
NCT WISH’s fourth mini-album, “I SPY,” is set to be released on the 12th. It features a total of six tracks, including the title track of the same name, and marks their first new release in about six months since their first full-length album, “Ode to Love,” released last April.
Meanwhile, NCT WISH has achieved three consecutive million-seller albums with “Ode to Love.” Their Japanese single “YO-I-DON!·BOY MEETS GIRL,” released last July, surpassed cumulative shipments of 500,000 copies and received a Double Platinum certification from the Recording Industry Association of Japan.
(Photo: Blind)
One of the concerns facing the Lee Jae-myung administration is the decline in support among young people. According to Gallup Korea’s presidential job approval ratings, the approval…
The KRX Health Care Index rose 4.53% from the previous session on Oct. 1, signaling a rare tailwind for South Korea’s pharmaceutical and biotech sector. Among the gainers, GIInnovation and G2GBio drew…
(Graphic: ChatGPT)
“While existing ex vivo chimeric antigen receptor T-cell (CAR-T) therapies are personalized treatments that require cell collection from each patient for manufacturing, the in v…